<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02353325</url>
  </required_header>
  <id_info>
    <org_study_id>Omnisalt</org_study_id>
    <nct_id>NCT02353325</nct_id>
  </id_info>
  <brief_title>Iron Bioavailability From Encapsulated Ferrous Sulphate</brief_title>
  <official_title>Iron Bioavailability From Salt Fortified With Ferrous Sulphate, Zinc Sulphate and Ascorbic Acid Encapsulated in a Polymer Jacket</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Salt is one of the very few regularly purchased food item in all socioeconomic classes
      including poor remote areas with subsistence farming. Therefore, it is a promising vehicle
      for fortification with micronutrients, such as iodine, iron, vitamin A, to alleviate the
      burden of micronutrient deficiencies. However, ensuring the bioavailability of iron and the
      sensory quality in fortified salt is difficult. Water-soluble iron compounds, such as ferrous
      sulphate FeSO4, are the most bioavailable, but they react with moisture and impurities in
      salt, and cause unacceptable changes in colour. Encapsulation can reduce iron-mediated colour
      change in fortified salt without significantly compromise bioavailability. In the present
      project we aim to investigate the iron bioavailability from salt fortified with FeSO4 using a
      new encapsulation type based on hyaluronic acid (HA) and a polymer from the eudragit family
      (EPO).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in the isotopic ratio of iron in blood at week 2</measure>
    <time_frame>baseline, 2 weeks</time_frame>
    <description>The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from week 2 in the isotopic ratio of iron in blood at week 4</measure>
    <time_frame>2 weeks, 4 weeks</time_frame>
    <description>The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Iron Deficiency</condition>
  <arm_group>
    <arm_group_label>non-encapsulated FeSO4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4, before cooking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4, added before cooking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4, after cooking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4, added after cooking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-encapsulated FeSO4 + ascorbic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4 and ascorbic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 + ascorbic acid, before cooking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4 and ascorbic acid, added before cooking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>encapsulated FeSO4 + ascorbic acid, after cooking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maize porridge with salt fortified with non-encapsulated FeSO4 and ascorbic acid, added after cooking</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-encapsulated FeSO4</intervention_name>
    <arm_group_label>non-encapsulated FeSO4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4, before cooking</intervention_name>
    <arm_group_label>encapsulated FeSO4, before cooking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4, after cooking</intervention_name>
    <arm_group_label>encapsulated FeSO4, after cooking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-encapsulated FeSO4 + ascorbic acid</intervention_name>
    <arm_group_label>non-encapsulated FeSO4 + ascorbic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 + ascorbic acid, before cooking</intervention_name>
    <arm_group_label>encapsulated FeSO4 + ascorbic acid, before cooking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>encapsulated FeSO4 + ascorbic acid, after cooking</intervention_name>
    <arm_group_label>encapsulated FeSO4 + ascorbic acid, after cooking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, 18 to 40 years old

          -  Marginal iron status (ferritin &lt; 25 ng/ml)

          -  Body weight &lt; 65 kg

          -  Normal body Mass Index (18.5 - 25 kg/m2)

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy (assessed by a pregnancy test) / intention to become pregnant

          -  Lactating up to 6 weeks before study initiation

          -  Moderate or severe anaemia (hemoglobin &lt; 9.0 g/dL)

          -  Elevated C-reactive protein (&gt; 5.0 mg/L)

          -  Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis,
             hypertension, cancer or cardiovascular diseases (according to the participants own
             statement)

          -  Continuous/long-term use of medication during the whole study (except for
             contraceptives)

          -  Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal
             administration

          -  Blood transfusion, blood donation or significant blood loss (accident, surgery) over
             the past 4 months

          -  Earlier participation in a study using Fe stable isotopes or participation in any
             clinical study within the last 30 days

          -  Participant who cannot be expected to comply with study protocol (e.g. not available
             on certain study appointments or difficulties with blood sampling)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Human Nutrition Laboratory, ETH Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8092</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>June 9, 2017</last_update_submitted>
  <last_update_submitted_qc>June 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iron deficiency</keyword>
  <keyword>Iron fortification</keyword>
  <keyword>Iron encapsulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Fesoterodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

